Approval · Notice of Compliance 5460 · 1994
DAYPRO: Notice of Compliance 5460
Issued February 10, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5460
- Date
- February 10, 1994
- Company
- Searle Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate source of active ingredient, change in formulation, change in manufacturing
- Therapeutic class
- Anti-inflammatory, analgesic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DAYPRO | Not yet assigned | — |
Medicinal ingredients
- OXAPROZIN 600 MG per TAB